drugset / Trial / NCT07549828
Sebum Metabolomics and Lipidomics for Clinical Applications
NaSingle-groupOpen-labelBasic science
Summary
This study aims to develop a standardized workflow for sebum sampling and metabolomics/lipidomics analysis using Sebutape. A total of 200 participants will be recruited, including healthy individuals, patients with skin diseases, individuals undergoing dermatological treatments or using skincare products, and a subset of healthy participants receiving short-term topical antibiotic intervention. The study will investigate sebum composition, skin microbiome profiles, and their interactions under different conditions to explore potential biomarkers and clinical applications.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2029-03-31
- Completion
- 2029-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bacitracin | Unknown | — | Topical |
| Subject | Neomycin | Unknown | — | Topical |
| Subject | Polymyxin B | Peptide | — | Topical |